Category: Wright Medical Group Inc.
Wright Medical says it completed its $80 million acquisition of French medical device company Biotech International.
Wright Medical (NSDQ:WMGI) said the $80 million buyout of French orthopedic implant maker Biotech International it announced last month is on the books and could push its full-year sales to the higher end of its guidance.
Wright Medical gets a date with the FDA and a chance to have the agency withdraw its "not approvable" letter for Wright's Augment bone graft; net losses soar in Q3 on accounting write offs.
Wright Medical (NSDQ:WMGI) officials said the FDA has agreed to hold a dispute resolution panel for the orthopedic company's Augment Bone Graft product, which was denied approval by the agency in August.
Wright Medical says it's agreed to pay up to $80 million for French orthopedic extremities firm Biotech International.
Wright Medical (NSDQ:WMGI) said today that it agreed to pony up some $80 million for a French medical device company, Biotech International, that makes orthopedic devices for the extremities.
Wright Medical shares take a dive after it reveals a non-approvable letter from the FDA for the Augment bone graft it acquired along with BioMimetic Therapeutics last year.
Wright Medical (NSDQ:WMGI) shares are down nearly 9% today after the medical device company revealed that the FDA won't approve its Augment bone graft.
Wright Medical Group posts a 2nd-quarter loss on charges related to the sale of its hip & knee implant business and the acquisition of BioMimetic Therapeutics.
Second-quarter losses grew for Wright Medical (NSDQ:WMGI) as the medical device company continued to absorb its acquisition of BioMimetic Therapeutics and to deal with the sale of its hip & knee implant business.
New SpineVision COO Ken Yamada joins the company's U.S. operations after 2 years at Wright Medical Technology.
SpineVision pulled in former Wright Medical (NSDQ:WMGI) executive Ken Yamada as its new chief of operations for its U.S. subsidiary.
The new COO worked at at Wright for 2 years as the VP of international operations and has 17 years experience at medical companies.
American medical device companies are supposed to buy Chinese med-tech companies and not the other way around, right? Not anymore.
By Stephen Simpson
Apparently MicroPort and Wright Medical (NSDQ:WMGI) didn't get the memo – American med-tech companies are supposed to buy Chinese med-tech companies and not the other way around. But in a surprising announcement Wednesday night, the two companies revealed that MicroPort has reached an agreement to acquire Wright Medical's OrthoRecon business for $290 million in cash.